We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NVCR market cap is 1.85B. The company's latest EPS is USD -1.9135 and P/E is -8.92.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 127.32M | 133.78M | 138.5M | 150.36M | 155.1M |
| Operating Income | -56.85M | -53.9M | -40.91M | -32.93M | -32.6M |
| Net Income | -49.49M | -47.08M | -38.76M | -33.38M | -30.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 351.32M | 494.37M | 535.03M | 537.84M | 509.34M |
| Operating Income | -1.83M | 30.4M | -44.33M | -89.52M | -232.87M |
| Net Income | -7.23M | 19.81M | -58.35M | -92.53M | -207.04M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.15B | 1.15B | 1.12B | 1.21B | 1.22B |
| Total Liabilities | 752.65M | 783.63M | 762.07M | 850.42M | 861.21M |
| Total Equity | 393.7M | 362.5M | 359.36M | 361.75M | 360.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 479.45M | 1.05B | 1.14B | 1.19B | 1.15B |
| Total Liabilities | 261.66M | 575.46M | 729M | 750.48M | 783.63M |
| Total Equity | 217.79M | 476.53M | 410.49M | 441.17M | 362.5M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -58.78M | -73.34M | -31.57M | -33.29M | -22.92M |
| Investing | 85.65M | 184.15M | 246.22M | -128.22M | -118.03M |
| Financing | 13.88M | 15.79M | 213k | 87.53M | 87.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 26.62M | 99.15M | 82.76M | 30.79M | -73.34M |
| Investing | -51.67M | -472.85M | -144.83M | -139.96M | 184.15M |
| Financing | 61.68M | 440.21M | 25.7M | 15.49M | 15.79M |
| Market Cap | 1.85B |
| Price to Earnings Ratio | -8.92 |
| Price to Sales Ratio | 3.62 |
| Price to Cash Ratio | 7.67 |
| Price to Book Ratio | 5.09 |
| Dividend Yield | - |
| Shares Outstanding | 108.2M |
| Average Volume (1 week) | 732.02k |
| Average Volume (1 Month) | 909.15k |
| 52 Week Change | 41.93% |
| 52 Week High | 24.735 |
| 52 Week Low | 11.29 |
| Spread (Intraday) | 0.02 (0.12%) |
| Company Name | NovoCure Ltd |
| Address |
no 4 the forum jersey JE2 4UF |
| Website | https://www.novocure.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
